Across TCGA pan-cancer cohorts, CDY10P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of CDY10P’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where CDY10P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CDY10P is over-expressed in tumor.

PRAD are the cancer types where CDY10P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDY10P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.011	.048	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CDY10P RNA expression & survival · all CDY10P data types